| Old Articles: <Older 9091-9100 Newer> |
|---|
 |
Chemistry World
May 26, 2015
Phillip Broadwith |
Endo to buy Par as generics consolidation continues Irish-headquartered firm Endo Pharmaceuticals has agreed to buy private US firm Par Pharmaceuticals in a deal worth around $8 billion in a combination of cash, shares and assumed debt.   |
Chemistry World
May 20, 2015
Andy Extance |
Malaria drug could cash in on green chemistry Green chemistry principles could make synthesizing the frontline antimalarial drug artemisinin both cleaner and cheaper, an industry -- academia collaboration suggests. |
Chemistry World
May 19, 2015
Anthony King |
Roadmap to reward pharma for creating new antibiotics unveiled Pharma firms need better incentives to create novel antibiotics to head off an 'apocalyptic scenario' where commonplace infections become deadly once more. |
Chemistry World
May 19, 2015
Phillip Broadwith |
GSK commits to HIV research GlaxoSmithKline has reaffirmed its commitment to researching new drugs for HIV -- Aids, by partnering with the University of North Carolina in Chapel Hill, US. |
Information Today
May 19, 2015 |
Wolters Kluwer Health and NextGen Healthcare Integrate Solutions NextGen Healthcare will integrate Wolters Kluwer Health's ProVation Clinic Note into its NextGen Now platform. |
Chemistry World
May 15, 2015
Rebecca Trager |
Trade agreement could limit access to medicines A leaked draft of a trade agreement under negotiation among 12 Pacific rim countries, including the US and Japan, contains language that could delay the entrance of generic competition for much-needed medicines. |
Chemistry World
May 14, 2015
Rebecca Trager |
Injunction blocks first US biosimilar A US federal circuit court has granted a request by Amgen to temporarily block sales of the first biosimilar product approved by the US Food and Drug Administration |
Chemistry World
May 14, 2015
Rebecca Trager |
FDA accused of violating drug company's freedom of speech The US Food and Drug Administration is under pressure to reconsider its policy prohibiting pharmaceutical companies from promoting 'off-label' uses of their products. |
Information Today
May 14, 2015 |
NPG Announces Spinal Cord Journal Nature Publishing Group introduced a quarterly, online-only journal, Spinal Cord Series and Cases, in collaboration with the International Spinal Cord Society. |
Chemistry World
May 12, 2015
Phillip Broadwith |
Alexion to buy Synageva for rare disease drugs Rare disease drugmaker Alexion has agreed to buy US biotech Synageva for $8.4 billion in a mix of cash and shares. |
| <Older 9091-9100 Newer> Return to current articles. |
